Shandong Buchang Pharmaceuticals Co (SHSE:603858) Interest Expense : ¥-113 Mil (TTM As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Shandong Buchang Pharmaceuticals Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Shandong Buchang Pharmaceuticals Co's interest expense for the three months ended in Mar. 2024 was ¥ -29 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-113 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Shandong Buchang Pharmaceuticals Co's Operating Income for the three months ended in Mar. 2024 was ¥ 219 Mil. Shandong Buchang Pharmaceuticals Co's Interest Expense for the three months ended in Mar. 2024 was ¥ -29 Mil. Shandong Buchang Pharmaceuticals Co's Interest Coverage for the quarter that ended in Mar. 2024 was 7.47. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Shandong Buchang Pharmaceuticals Co Interest Expense Historical Data

The historical data trend for Shandong Buchang Pharmaceuticals Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Buchang Pharmaceuticals Co Interest Expense Chart

Shandong Buchang Pharmaceuticals Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-136.78

-145.05

-167.29

-135.10

-109.93

Shandong Buchang Pharmaceuticals Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-26.27	-26.27	-32.32	-25.07	-29.35

Shandong Buchang Pharmaceuticals Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-113 Mil.

Shandong Buchang Pharmaceuticals Co (SHSE:603858) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Shandong Buchang Pharmaceuticals Co's Interest Expense for the three months ended in Mar. 2024 was ¥-29 Mil. Its Operating Income for the three months ended in Mar. 2024 was ¥219 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was ¥2,557 Mil.

Shandong Buchang Pharmaceuticals Co's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2024 )	/	Interest Expense (Q: Mar. 2024 )
	=	-1	*	219.132	/	-29.353
	=	7.47

The higher the ratio, the stronger the company's financial strength is.

Shandong Buchang Pharmaceuticals Co (SHSE:603858) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shandong Buchang Pharmaceuticals Co Ltd (SHSE:603858) » Definitions » Interest Expense

Traded in Other Exchanges

N/A

Address

No. 369, Zhonghua West Road, Shandong Province, Heze, CHN, 274000

Website

http://www.buchang.com

Shandong Buchang Pharmaceuticals Co Ltd is a pharmaceuticals company engaged in drug manufacturing. It specializes in the research and development, production and sale of Traditional Chinese patent medicines, supplemented by fields such as hi-tech industry and health industry. The company offers drugs for cardiac and cerebral vascular disease, diabetes, urinary and digestive disease, respiratory disease, gynecological disease and others. Geographically, the company holds its production bases in Shandong, Shaanxi, Hebei and Northeast China, with its marketing network spreading all over the major provinces of China.

Shandong Buchang Pharmaceuticals Co (SHSE:603858) Headlines

No Headlines